Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Novel molecular insights on vertebrate genome stability maintenance

Dr Vincenzo Costanzo – IFOM-IEO, Milan, Italy
Novel molecular insights on vertebrate genome stability maintenance ( Dr Vincenzo Costanzo – IFOM-IEO, Milan, Italy )
21 Nov 2012

Stem cell generation of tumors and tissue physiology

Dr Colin Jamora – IFOM – Institute for Stem Cell Biology and Regenerative Medicine, India
Stem cell generation of tumors and tissue physiology ( Dr Colin Jamora – IFOM – Institute for Stem Cell Biology and Regenerative Medicine, India )
21 Nov 2012

Regulating the p53 pathway

Dr David Lane – Agency for Science, Technology and Research, Singapore
Regulating the p53 pathway ( Dr David Lane – Agency for Science, Technology and Research, Singapore )
21 Nov 2012

Targeted therapies for colorectal cancer

Dr Alberto Bardelli – IFOM – University of Turin-Medical School, Italy
Targeted therapies for colorectal cancer ( Dr Alberto Bardelli – IFOM – University of Turin-Medical School, Italy )
21 Nov 2012

Colon cancer microenvironments preventing invasion and metastasis

Dr Makoto Mark Taketo – Kyoto University Graduate School of Medicine, Japan
Colon cancer microenvironments preventing invasion and metastasis ( Dr Makoto Mark Taketo – Kyoto University Graduate School of Medicine, Japan )
20 Nov 2012

RAB5, master regulator of tumour, mesenchymal invasive programmes

Dr Giorgio Scita – IFOM University of Milan, Italy
RAB5, master regulator of tumour, mesenchymal invasive programmes ( Dr Giorgio Scita – IFOM University of Milan, Italy )
20 Nov 2012

Patient led funding for clinical trials

Dr Ian Lewis – Tenovus, Cardiff, UK
Patient led funding for clinical trials ( Dr Ian Lewis – Tenovus, Cardiff, UK  )
15 Nov 2012

Advances in haemato-oncological treatment options

Prof Kenneth Anderson – Dana Farber Cancer Institute, Boston, UK
Advances in haemato-oncological treatment options ( Prof Kenneth Anderson – Dana Farber Cancer Institute, Boston, UK )
15 Nov 2012

Highlights from the 4th EUTROC meeting

Prof John Green – University of Liverpool, UK
Highlights from the 4th EUTROC meeting ( Prof John Green – University of Liverpool, UK )
15 Nov 2012

Histological and molecular sub types of ovarian cancer

Dr Jozien Helleman – Erasmus Medical Centre, Rotterdam, Netherlands
Histological and molecular sub types of ovarian cancer ( Dr Jozien Helleman – Erasmus Medical Centre, Rotterdam, Netherlands )
15 Nov 2012

The AKT pathway and chemotherapy resistant ovarian cancer

Dr Euan Stronach – Imperial College London, UK
The AKT pathway and chemotherapy resistant ovarian cancer ( Dr Euan Stronach – Imperial College London, UK )
15 Nov 2012

Ovarian cancer tumour banks and collaboration

Dr Elena Braicu - Charite University Hospital, Berlin, Germany
Ovarian cancer tumour banks and collaboration ( Dr Elena Braicu - Charite University Hospital, Berlin, Germany )
15 Nov 2012